A large European population study found no association between some LRP2 polymorphism and eGFR decline [22], while a study of African Americans revealed a novel missense LRP2 mutation that protected from type 2-diabetes mellitus-associated end-stage kidney disease [23]. Here, LRP2 is linked to diabetes mellitus.